cas 1260088-68-3|| where to buy 1-(Oxetan-3-yl)-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea

Название продукции:1-(Oxetan-3-yl)-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea

IUPAC Name:3-(oxetan-3-yl)-1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]urea

: CAS：1260088-68-3; Молекулярная формула：C16H23BN2O4; Чистота：95%

Упаковочная единица	Доступно для заказа	Цена ($)	Количество
CM136759-1g	in stock	ƙɅɅƙ

Только для использования в НИОКР..

Форма запроса

Химическое название

Номер CAS

Количество*

Необходимые спецификации*
(% пробы, категория материала и т.д.)

Контактное лицо*

Электронная почта*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1260088-68-3 regularly via the above email.

Дополнительные примечания

Verification code*

refresh

: Номер CAS:1260088-68-3; Молекулярная формула:C16H23BN2O4; Точка плавления:-; Smiles-код:O=C(NC1=CC=C(B2OC(C)(C)C(C)(C)O2)C=C1)NC3COC3; Плотность:

: Номер в каталоге:CM136759; Молекулярная масса:318.18; Точка кипения:; Номер Mdl:MFCD22690835; Хранение:

: Oxetanes; Oxygen heterocycles are one of the most common heterocycles in drugs and natural products. Oxetene has high polarity and is also a good acceptor for hydrogen bond, which contributes to the metabolism and chemical stability of its host molecules. When substituted for commonly used functional groups such as gem dimethyl or carbonyl, oxetane units can induce profound changes in water solubility, lipophilicity, metabolic stability and conformational preference. Four of the FDA-approved drugs contain oxetenes: Orlistat, Paclitaxel, and two of its derivatives, Docetaxel and Cabazitaxel. Currently, oxetane-containing building blocks are flourishing in medicinal chemistry and drug discovery.

: Boronic Acids and Esters; Boronic acids and boronate esters are commonly used reagents in Suzuki–Miyaura coupling chemistry. Organoboron derivatives are common reagents for C–C bond formation, either through classical palladium-mediated transformations or through other newer coupling methods. Boronic esters and acids are potential intermediates in the manufacture of many active pharmaceutical ingredients (API).